Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Dubé E[au]:

Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Dubé E et al. Expert Rev Vaccines. (2015)

Vaccine hesitancy: an overview. Dubé E et al. Hum Vaccin Immunother. (2013)

Vaccine Hesitancy: In Search of the Risk Communication Comfort Zone. Greenberg J et al. PLoS Curr. (2017)

Search results

Items: 1 to 50 of 139

1.

Towards a further understanding of measles vaccine hesitancy in Khartoum state, Sudan: A qualitative study.

Sabahelzain MM, Moukhyer M, Dubé E, Hardan A, van den Borne B, Bosma H.

PLoS One. 2019 Jun 20;14(6):e0213882. doi: 10.1371/journal.pone.0213882. eCollection 2019.

2.

Addressing vaccine hesitancy in immunization programs, clinics and practices.

MacDonald NE, Dubé E.

Paediatr Child Health. 2018 Dec;23(8):559-560. doi: 10.1093/pch/pxy131. Epub 2018 Nov 19. English, French.

PMID:
31043843
3.

Is physician dismissal of vaccine refusers an acceptable practice in Canada? A 2018 overview.

MacDonald NE, Harmon S, Dube E, Taylor B, Steenbeek A, Crowcroft N, Graham J.

Paediatr Child Health. 2019 May;24(2):92-97. doi: 10.1093/pch/pxy116. Epub 2018 Oct 1. Review.

PMID:
30996599
4.

Socioeconomic status differences in parental immunization attitudes and child immunization in Canada: Findings from the 2013 Childhood National Immunization Coverage Survey (CNICS).

Carpiano RM, Polonijo AN, Gilbert N, Cantin L, Dubé E.

Prev Med. 2019 Jun;123:278-287. doi: 10.1016/j.ypmed.2019.03.033. Epub 2019 Mar 20.

PMID:
30904601
5.

Seasonal influenza self-vaccination behaviours and attitudes among nurses in Southeastern France.

Wilson R, Scronias D, Zaytseva A, Ferry MA, Chamboredon P, Dubé E, Verger P.

Hum Vaccin Immunother. 2019 Mar 4:1-11. doi: 10.1080/21645515.2019.1587274. [Epub ahead of print]

PMID:
30829102
6.

Promoting vaccination in the province of Québec: the PromoVaQ randomized controlled trial protocol.

Gagneur A, Quach C, Boucher FD, Tapiero B, De Wals P, Farrands A, Lemaitre T, Boulianne N, Sauvageau C, Ouakki M, Gosselin V, Gagnon D, Petit G, Jacques MC, Dubé È.

BMC Public Health. 2019 Feb 6;19(1):160. doi: 10.1186/s12889-019-6468-z.

7.

Systematic review searches must be systematic, comprehensive, and transparent: a critique of Perman et al.

Greyson D, Rafferty E, Slater L, MacDonald N, Bettinger JA, Dubé È, MacDonald SE.

BMC Public Health. 2019 Feb 4;19(1):153. doi: 10.1186/s12889-018-6275-y.

8.

Relapse pattern and long-term outcomes in subjects with acquired haemophilia A.

Mizrahi T, Doyon K, Dubé E, Bonnefoy A, Warner M, Cloutier S, Demers C, Castilloux JF, Rivard GE, St-Louis J.

Haemophilia. 2019 Mar;25(2):252-257. doi: 10.1111/hae.13685. Epub 2019 Jan 29.

PMID:
30694571
9.

Challenges in diagnosis of von Willebrand disease in the presence of combined mutations of different genes.

Nava T, Dubé E, Gauthier J, Vézina C, Bonnefoy A, Lillicrap D, Rivard GE.

Haemophilia. 2019 Mar;25(2):e113-e117. doi: 10.1111/hae.13686. Epub 2019 Jan 28. No abstract available.

PMID:
30690834
10.

Photophysicochemical and photodynamic therapy properties of metallophthalocyanines linked to gold speckled silica nanoparticles.

Dube E, Oluwole DO, Njemuwa N, Prinsloo E, Nyokong T.

Photodiagnosis Photodyn Ther. 2019 Mar;25:325-333. doi: 10.1016/j.pdpdt.2019.01.019. Epub 2019 Jan 15.

PMID:
30658105
11.

Impact of Audits and Multifaceted Intervention on Vaginal Birth After Caesarean: Secondary Analysis of the QUARISMA Trial.

Roberge S, Boutin A, Bujold E, Dubé E, Blouin S, Chaillet N.

J Obstet Gynaecol Can. 2019 May;41(5):608-615. doi: 10.1016/j.jogc.2018.05.044. Epub 2019 Jan 11.

PMID:
30642816
12.

Challenges and opportunities of school-based HPV vaccination in Canada.

Dubé E, Gagnon D, Clément P, Bettinger JA, Comeau JL, Deeks S, Guay M, MacDonald S, MacDonald NE, Mijovic H, Paragg J, Rubincam C, Sauvageau C, Steenbeck A, Wilson S; Canadian Immunization Research Network.

Hum Vaccin Immunother. 2019;15(7-8):1650-1655. doi: 10.1080/21645515.2018.1564440. Epub 2019 Feb 20.

PMID:
30633622
13.

Vaccine acceptance: Science, policy, and practice in a 'post-fact' world.

Attwell K, Dube E, Gagneur A, Omer SB, Suggs LS, Thomson A.

Vaccine. 2019 Jan 29;37(5):677-682. doi: 10.1016/j.vaccine.2018.12.014. Epub 2019 Jan 4.

PMID:
30616955
14.

Interventions to help people understand community immunity: A systematic review.

Hakim H, Provencher T, Chambers CT, Driedger SM, Dube E, Gavaruzzi T, Giguere AMC, Ivers NM, MacDonald S, Paquette JS, Wilson K, Reinharz D, Witteman HO.

Vaccine. 2019 Jan 7;37(2):235-247. doi: 10.1016/j.vaccine.2018.11.016. Epub 2018 Dec 6.

PMID:
30528593
15.

Vaccination Against Influenza in Pregnancy: A Survey of Canadian Maternity Care Providers.

Dubé E, Gagnon D, Kaminsky K, Green CR, Ouakki M, Bettinger JA, Brousseau N, Castillo E, Crowcroft NS, Driedger SM, Greyson D, Fell D, Fisher W, Gagneur A, Guay M, Halperin D, Halperin SA, MacDonald S, Meyer SB, Waite NM, Wilson K, Witteman HO, Yudin M, Cook JL; Canadian Immunization Network.

J Obstet Gynaecol Can. 2019 Apr;41(4):479-488. doi: 10.1016/j.jogc.2018.09.007. Epub 2018 Nov 6.

PMID:
30409569
16.

Underlying factors impacting vaccine hesitancy in high income countries: a review of qualitative studies.

Dubé E, Gagnon D, MacDonald N, Bocquier A, Peretti-Watel P, Verger P.

Expert Rev Vaccines. 2018 Nov;17(11):989-1004. doi: 10.1080/14760584.2018.1541406. Epub 2018 Nov 7. Review.

PMID:
30359151
17.

Determinants of non-vaccination against seasonal influenza.

Roy M, Sherrard L, Dubé È, Gilbert NL.

Health Rep. 2018 Oct 17;29(10):12-22.

18.

Motivational interviewing: A promising tool to address vaccine hesitancy.

Gagneur A, Gosselin V, Dubé È.

Vaccine. 2018 Oct 22;36(44):6553-6555. doi: 10.1016/j.vaccine.2017.10.049. Epub 2018 Jul 26. No abstract available.

PMID:
30301523
19.

Expected challenges of implementing universal pertussis vaccination during pregnancy in Quebec: a cross-sectional survey.

Brousseau N, Gagnon D, Vivion M, Poliquin V, Boucoiran I, Tapiéro B, Dubé E.

CMAJ Open. 2018 Sep 20;6(3):E391-E397. doi: 10.9778/cmajo.20180040. Print 2018 Jul-Sep.

20.

Gender differences in egalitarian behavior and attitudes in early childhood.

Benenson JF, Durosky A, Nguyen J, Crawford A, Gauthier E, Dubé É.

Dev Sci. 2019 Mar;22(2):e12750. doi: 10.1111/desc.12750. Epub 2018 Oct 2.

PMID:
30176104
21.

Mandatory infant & childhood immunization: Rationales, issues and knowledge gaps.

MacDonald NE, Harmon S, Dube E, Steenbeek A, Crowcroft N, Opel DJ, Faour D, Leask J, Butler R.

Vaccine. 2018 Sep 18;36(39):5811-5818. doi: 10.1016/j.vaccine.2018.08.042. Epub 2018 Aug 22. Review.

22.

Overview of knowledge, attitudes, beliefs, vaccine hesitancy and vaccine acceptance among mothers of infants in Quebec, Canada.

Dubé È, Farrands A, Lemaitre T, Boulianne N, Sauvageau C, Boucher FD, Tapiero B, Quach C, Ouakki M, Gosselin V, Gagnon D, De Wals P, Petit G, Jacques MC, Gagneur A.

Hum Vaccin Immunother. 2019;15(1):113-120. doi: 10.1080/21645515.2018.1509647. Epub 2018 Sep 11.

PMID:
30095325
23.

Effect of ABO blood group on haemostatic parameters in severe haemophilia A patients performing acute moderate-intensity exercise.

Merlen C, Zourikian N, Bonnefoy A, Dubé E, Thibeault C, St-Louis J, Rivard GE.

Blood Coagul Fibrinolysis. 2018 Nov;29(7):626-635. doi: 10.1097/MBC.0000000000000762.

PMID:
30036280
24.

Determinants of non-vaccination against seasonal influenza in Canadian adults: findings from the 2015-2016 Influenza Immunization Coverage Survey.

Farmanara N, Sherrard L, Dubé È, Gilbert NL.

Can J Public Health. 2018 Jun;109(3):369-378. doi: 10.17269/s41997-018-0018-9. Epub 2018 Mar 30.

25.

Managing flood disasters on the built environment in the rural communities of Zimbabwe: Lessons learnt.

Dube E, Mtapuri O, Matunhu J.

Jamba. 2018 May 30;10(1):542. doi: 10.4102/jamba.v10i1.542. eCollection 2018.

26.

The contribution of indigenous knowledge to disaster risk reduction activities in Zimbabwe: A big call to practitioners.

Dube E, Munsaka E.

Jamba. 2018 Mar 26;10(1):493. doi: 10.4102/jamba.v10i1.493. eCollection 2018. Review.

27.

Flooding and poverty: Two interrelated social problems impacting rural development in Tsholotsho district of Matabeleland North province in Zimbabwe.

Dube E, Mtapuri O, Matunhu J.

Jamba. 2018 Mar 22;10(1):455. doi: 10.4102/jamba.v10i1.455. eCollection 2018.

28.

Comparison of response rates on invitation mode of a web-based survey on influenza vaccine adverse events among healthcare workers: a pilot study.

Tai X, Smith AM, McGeer AJ, Dubé E, Holness DL, Katz K, McGillis Hall L, McNeil SA, Powis J, Coleman BL.

BMC Med Res Methodol. 2018 Jun 20;18(1):59. doi: 10.1186/s12874-018-0524-8.

29.

Photophysicochemical properties and photodynamic therapy activity of highly water-soluble Zn(II) phthalocyanines.

Oluwole DO, Sarı FA, Prinsloo E, Dube E, Yuzer A, Nyokong T, Ince M.

Spectrochim Acta A Mol Biomol Spectrosc. 2018 Oct 5;203:236-243. doi: 10.1016/j.saa.2018.05.090. Epub 2018 May 29.

PMID:
29870908
30.

Glycosylated zinc phthalocyanine-gold nanoparticle conjugates for photodynamic therapy: Effect of nanoparticle shape.

Dube E, Oluwole DO, Nwaji N, Nyokong T.

Spectrochim Acta A Mol Biomol Spectrosc. 2018 Oct 5;203:85-95. doi: 10.1016/j.saa.2018.05.081. Epub 2018 May 28.

PMID:
29860172
31.

Educating children and adolescents about vaccines: a review of current literature.

Maisonneuve AR, Witteman HO, Brehaut J, Dubé È, Wilson K.

Expert Rev Vaccines. 2018 Apr;17(4):311-321. doi: 10.1080/14760584.2018.1456921. Epub 2018 Apr 12. Review. Erratum in: Expert Rev Vaccines. 2018 Apr;17 (4):1.

PMID:
29569498
32.

The next vaccine-autism question: Are school-aged youth with autism spectrum disorder undervaccinated and, if so, why?

Filliter JH, Dodds L, MacDonald N, Shea S, Dubé E, Smith IM, Campbell LA.

Paediatr Child Health. 2017 Aug;22(5):285-287. doi: 10.1093/pch/pxx083. Epub 2017 Jun 22.

33.

A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third-generation B-domain-deleted recombinant factor VIII.

Dubé E, Bonnefoy A, Merlen C, Castilloux JF, Cloutier S, Demers C, Sabapathy CA, St-Louis J, Vezina C, Warner M, Rivard GÉ.

Haemophilia. 2018 Mar;24(2):236-244. doi: 10.1111/hae.13410. Epub 2018 Feb 1.

PMID:
29388742
34.

The vaccine hesitancy scale: Psychometric properties and validation.

Shapiro GK, Tatar O, Dube E, Amsel R, Knauper B, Naz A, Perez S, Rosberger Z.

Vaccine. 2018 Jan 29;36(5):660-667. doi: 10.1016/j.vaccine.2017.12.043. Epub 2017 Dec 27.

PMID:
29289384
35.

The WHO Tailoring Immunization Programmes (TIP) approach: Review of implementation to date.

Dubé E, Leask J, Wolff B, Hickler B, Balaban V, Hosein E, Habersaat K.

Vaccine. 2018 Mar 7;36(11):1509-1515. doi: 10.1016/j.vaccine.2017.12.012. Epub 2017 Dec 26.

36.

Improved Photophysical and Photochemical Properties of Thiopheneethoxy Substituted Metallophthalocyanines on Immobilization onto Gold-speckled Silica Nanoparticles.

Dube E, Oluwole DO, Nyokong T.

Photochem Photobiol. 2018 May;94(3):521-531. doi: 10.1111/php.12879. Epub 2018 Mar 25.

PMID:
29274109
37.

Measuring vaccine acceptance among Canadian parents: A survey of the Canadian Immunization Research Network.

Dubé E, Gagnon D, Ouakki M, Bettinger JA, Witteman HO, MacDonald S, Fisher W, Saini V, Greyson D; Canadian Immunization Research Network.

Vaccine. 2018 Jan 25;36(4):545-552. doi: 10.1016/j.vaccine.2017.12.005. Epub 2017 Dec 9.

PMID:
29233605
38.

Placental Lipid Transport.

Dubé E, Desparois G, Lafond J.

Methods Mol Biol. 2018;1710:305-316. doi: 10.1007/978-1-4939-7498-6_24.

PMID:
29197013
39.

Vaccine hesitancy terminology: A response to Bedford et al.

MacDonald N, Dubé E, Butler R.

Vaccine. 2019 Jul 9;37(30):3947-3948. doi: 10.1016/j.vaccine.2017.11.060. Epub 2017 Nov 26. No abstract available.

PMID:
29180029
40.

Addressing barriers to vaccine acceptance: an overview.

MacDonald NE, Butler R, Dubé E.

Hum Vaccin Immunother. 2018 Jan 2;14(1):218-224. doi: 10.1080/21645515.2017.1394533. Epub 2017 Nov 29.

41.

A cluster-randomized trial to reduce major perinatal morbidity among women with one prior cesarean delivery in Québec (PRISMA trial): study protocol for a randomized controlled trial.

Chaillet N, Bujold E, Masse B, Grobman WA, Rozenberg P, Pasquier JC, Shorten A, Johri M, Beaudoin F, Abenhaim H, Demers S, Fraser W, Dugas M, Blouin S, Dubé E, Gauthier R; PRISMA Trial Research Group.

Trials. 2017 Sep 20;18(1):434. doi: 10.1186/s13063-017-2150-x.

42.

Determinants of under-immunization and cumulative time spent under-immunized in a Quebec cohort.

O'Donnell S, Dubé E, Tapiero B, Gagneur A, Doll MK, Quach C.

Vaccine. 2017 Oct 13;35(43):5924-5931. doi: 10.1016/j.vaccine.2017.08.072. Epub 2017 Sep 4.

PMID:
28882440
43.

Vaccination resilience: Building and sustaining confidence in and demand for vaccination.

Dubé E, MacDonald NE.

Vaccine. 2017 Jul 13;35(32):3907-3909. doi: 10.1016/j.vaccine.2017.06.015. Epub 2017 Jun 13. No abstract available.

PMID:
28623026
44.

Exploring the acceptability of the available pneumococcal conjugate vaccines in Canadian health care professionals and immunization experts.

Berman M, Dubé E, Quach C.

Vaccine. 2017 Jun 5;35(25):3326-3332. doi: 10.1016/j.vaccine.2017.04.083. Epub 2017 May 10.

PMID:
28501455
45.
46.

Vaccine Hesitancy: In Search of the Risk Communication Comfort Zone.

Greenberg J, Dubé E, Driedger M.

PLoS Curr. 2017 Mar 3;9. pii: ecurrents.outbreaks.0561a011117a1d1f9596e24949e8690b. doi: 10.1371/currents.outbreaks.0561a011117a1d1f9596e24949e8690b.

47.

Knowledge, attitudes, beliefs, and behaviors of university students, faculty, and staff during a meningococcal serogroup B outbreak vaccination program.

MacDougall DM, Langley JM, Li L, Ye L, MacKinnon-Cameron D, Top KA, McNeil SA, Halperin BA, Swain A, Bettinger JA, Dubé E, De Serres G, Halperin SA; Canadian Immunization Research Network.

Vaccine. 2017 Apr 25;35(18):2520-2530. doi: 10.1016/j.vaccine.2017.02.011. Epub 2017 Mar 24.

PMID:
28347501
48.

Reporting Caesarean Delivery in Quebec Using the Robson Classification System.

Roberge S, Dubé E, Blouin S, Chaillet N.

J Obstet Gynaecol Can. 2017 Mar;39(3):152-156. doi: 10.1016/j.jogc.2016.10.010.

PMID:
28343556
49.

Thrombospondin-1-Derived Peptide RFYVVMWK Improves the Adhesive Phenotype of CD34+ Cells From Atherosclerotic Patients With Type 2 Diabetes.

Cointe S, Rhéaume É, Martel C, Blanc-Brude O, Dubé E, Sabatier F, Dignat-George F, Tardif JC, Bonnefoy A.

Cell Transplant. 2017 Feb 16;26(2):327-337. doi: 10.3727/096368916X693329. Epub 2016 Oct 6.

50.

Supplemental Content

Support Center